Cedar Fair, L.P (NYSE:FUN) reported below-consensus revenue and a $0.32 miss on earnings. The amusement park operator reported Q3 net income of $161.9 million, or $2.90 per share, missing the Capital IQ estimate of $3.22 per share. For the same quarter of 2013, FUN reported net income of $190.4 million, or $3.41 per share. Revenue totaled $595.3 million, below the estimated $605.34 million, but up slightly from $592.0 million for the same quarter last year. Also, the company declared a quarterly cash distribution of $0.75, a 7% increase from the prior quarter. The distribution is payable on December 15, 2014 to unitholders of record as of December 3. Shares of Cedar Fair, L.P (NYSE:FUN) last traded at $46.85 with a 52-week range of $42.75 to $55.77.Click Here for a Free Analysis of NYSE:FUN
Fred's, Inc. (NASDAQ:FRED) shares were lower in recent trade after reporting that comparable store sales fell 0.3% in Q3 and as it cut its earnings guidance for the quarter. Fred's, Inc. (NASDAQ:FRED) is trading in the lower half of the 52-week range between $13.07 and $21.05. The discount general merchandise store operator said it now expects to report a net loss in Q3 of $0.12 to $0.16, down from the previous guidance for a loss between $0.05 and $0.11. Analysts have been expecting a Q3 loss of $0.07. Comparable store sales fell 1.4% in October while total sales were higher 1.3% at $145.3 million. In Q3, total sales rose 3.4% to $476.1 million.Click Here for a Free Analysis of FRED
CEO Jerry Shore said sales were below the company's expectations and noted that noted that sales, inventory clean up, and clearance margin pressures experienced in earlier months have been the primary causes of the company's recent losses. "These pressures have clearly continued during the third quarter," the company said. "We know that the upcoming holiday season will be very competitive and internet shopping will continue to make gains, but the fourth quarter programs we have in place will meet the convenience dimension of our customers' shopping needs and drive more trips to our stores," Shore said. "Looking ahead to 2015, we are confident that the continued growth in pharmacy and the "need it now" front store layout will provide a strategic foundation for future growth and profitability."BioScrip Inc (NASDAQ:BIOS) a provider of infusion and home care management solutions, announced a wider loss per share than the same period a year ago and revenues that beat Street expectations. BioScrip Inc (NASDAQ:BIOS) reported a Q3 adjusted loss per share of $0.42, wider than the loss of $0.02 a year ago and missing analyst estimates of $0.02 in earnings for the quarter, if comparable. Total revenues of $243.95 million were up from $190.63 million in Q3 2013 but beat analyst projections of $242.8 million. The company has guided full-year revenue at the high end of the company's range of $940.0 million to $980.0 million. The Street is at $988 million.Click Here for a Free Analysis of BIOS
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
